Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Deferred Revenue (2016)

Amphastar Pharmaceuticals has reported Current Deferred Revenue over the past 4 years, most recently at $830000.0 for Q3 2016.

  • Quarterly results put Current Deferred Revenue at $830000.0 for Q3 2016, up 29.08% from a year ago — trailing twelve months through Sep 2016 was $830000.0 (up 29.08% YoY), and the annual figure for FY2015 was $643000.0, down 95.41%.
  • Current Deferred Revenue for Q3 2016 was $830000.0 at Amphastar Pharmaceuticals, down from $1.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for AMPH hit a ceiling of $14.6 million in Q3 2014 and a floor of $643000.0 in Q4 2013.
  • Median Current Deferred Revenue over the past 4 years was $830000.0 (2016), compared with a mean of $4.1 million.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 2079.32% in 2014 and later plummeted 95.59% in 2015.
  • Amphastar Pharmaceuticals' Current Deferred Revenue stood at $643000.0 in 2013, then skyrocketed by 2079.32% to $14.0 million in 2014, then tumbled by 95.41% to $643000.0 in 2015, then rose by 29.08% to $830000.0 in 2016.
  • The last three reported values for Current Deferred Revenue were $830000.0 (Q3 2016), $1.7 million (Q2 2016), and $643000.0 (Q1 2016) per Business Quant data.